FDA Approves First Ever Vaccine to Prevent Cervical Cancer
The Food and Drug Administration has given the green light to a new vaccine to prevent the human papillomavirus, or HPV, a sexually transmitted disease which is known to be a leading cause of cervical cancer. The vaccine, Gardasil, will be given in three doses over six months, and targets four HPV types experts say cause more than 70 percent of cervical cancer cases and 90 percent of genital warts. The vaccine was approved for use in girls and women ages 9 to 26.
For more information about the vaccine or cervical cancer visit: http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Or call the Vanderbilt-Ingram Cancer Center at: 1 (800) 811-8480.